Alles Mark J 4
4 · Syros Pharmaceuticals, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
Alles Mark J
Director
Transactions
- Award
Stock Option (right to buy)
2022-09-16+12,000→ 12,000 totalExercise: $7.35Exp: 2032-09-15→ Common Stock (12,000 underlying) - Award
Restricted Stock Units
2022-09-16+8,000→ 8,000 total→ Common Stock (8,000 underlying)
Footnotes (3)
- [F1]The option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date. Amounts reported in this Form 4 reflect the 1-for-10 reverse stock split effected by the issuer on September 16, 2022.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F3]These RSUs will vest in three equal annual installments commencing on September 16, 2023. Amounts reported in this Form 4 reflect the 1-for-10 reverse stock split effected by the issuer on September 16, 2022.